Cefepime is a broad-spectrum fourth-generation cephalosporin that achieves bactericidal effects by inhibiting the biosynthesis of bacterial cell walls. It is effective against both gram-positive and gram-negative bacteria, is highly resistant to hydrolysis by most beta-lactamases, and can quickly penetrate into the cells of gram-negative bacteria. Its target molecule is penicillin-binding protein (PBP). In vitro and clinical studies have confirmed that this product is active against a variety of microorganisms, including Enterobacter, Klebsiella pneumoniae, Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus aureus (methicillin-sensitive strains only), Streptococcus pyogenes (Group A Streptococcus), Streptococcus pneumoniae, etc.

As the precursor of oxaloacetate in the body, it plays an important role in the tricarboxylic acid cycle and participates in the ornithine cycle, combining ammonia and carbon dioxide to form urea. It has a strong affinity for cells and can be used as a carrier of potassium and magnesium ions to help them enter cells, increase the concentration of potassium and magnesium in cells, accelerate the tricarboxylic acid cycle of liver cells, and have a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

As a carrier of ions, it helps them enter cells, increases the concentration of potassium and magnesium in cells, accelerates the tricarboxylic acid cycle of liver cells, and has a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

As a carrier of ions, it helps them enter cells, increases the concentration of potassium and magnesium in cells, accelerates the tricarboxylic acid cycle of liver cells, and has a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

It improves blood rheology by reducing blood viscosity, reduces blood viscosity in a dose-dependent manner, improves red blood cell deformability, improves the blood rheology of white blood cells, and resists the adhesion and activation of neutrophils. For patients with chronic peripheral arterial vascular disease, it can increase blood flow, improve microcirculation and increase oxygen supply to tissues.

Bromide ions have the effect of inhibiting cerebral cortical activity and can be used for general sedation. Calcium ions also have a sedative effect, and the combination of the two can enhance the effect.

It enhances the body's disease resistance by regulating the body's cellular immunity, humoral immunity, stimulating the reticuloendothelial system, activating the function of monocytes and macrophages, and enhancing the function of natural killer cells; it achieves anti-allergic and anti-asthmatic effects by stabilizing mast cells, blocking IgE function, reducing the release of active substances from degranulated cells, and resisting bronchospasm caused by acetylcholine.

It enhances the body's disease resistance by regulating the body's cellular immunity, humoral immunity, stimulating the reticuloendothelial system, activating the function of monocytes and macrophages, and enhancing the function of natural killer cells; it achieves anti-allergic and anti-asthmatic effects by stabilizing mast cells, blocking IgE function, reducing the release of active substances from degranulated cells, and resisting bronchospasm caused by acetylcholine.